Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal (CASAD) for Treatment of Clostridium Difficile Infection
Clinical trial NCT01570634 · TERMINATED
Trial details
- NCT number
- NCT01570634
- Sponsor
- Salient Pharmaceuticals Incorporated
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2012-09-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.